Regorafenib and Methotrexate in Treating Participants With Recurrent or Metastatic KRAS Mutated Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Regorafenib
Related studies linked through entity extraction aliases.
A Study of CS1003 in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
(VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST
- Status
- COMPLETED
- Phase
- PHASE3
Regorafenib and Nivolumab Simultaneous Combination Therapy
- Status
- COMPLETED
- Phase
- PHASE1
An Investigational Immuno-therapy Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Participants With Previously Treated Cancer of the Colon or Rectum That Has Spread
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Regorafenib in Combination With TAS-102 in Subjects With Metastatic Colorectal Cancer Who Have Progressed After Standard Therapy
- Status
- COMPLETED
- Phase
- PHASE1
To Determine the Safety of Regorafenib, Hydroxychloroquine, and Entinostat Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Regorafenib Plus 5-Fluorouracil/Leucovorin Beyond Progression in mCRC
- Status
- TERMINATED
- Phase
- PHASE2
Phase Ib Study of PDR001 in Combination With Regorafenib in Adult Patients With Previously Treated Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of Regorafenib in Patients With Advanced Myeloid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Prospective Translational Study Investigating Molecular Predictors of Resistance and Response to Regorafenib Monotherapy
- Status
- COMPLETED
- Phase
- N/A
An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Metastatic Colorectal Cancer (RAS-wildtype) After Response to First-line Treatment With FOLFIR Plus Cetuximab
- Status
- COMPLETED
- Phase
- PHASE3
Regorafenib in Relapsed Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
The Drug Rediscovery Protocol (DRUP Trial)
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant Treatment With Regorafenib and Capecitabine Combined With Radiotherapy in Locally Advanced Rectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Phase II Study of Regorafenib Continuous Dosing of Regorafenib in Patients With GISTs
- Status
- COMPLETED
- Phase
- PHASE2
Study Comparing Different Dose Approaches of Induction Treatment of Regorafenib in MCRC
- Status
- COMPLETED
- Phase
- PHASE2
Study Assessing Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Investigate Efficacy and Safety of Cobimetinib Plus Atezolizumab and Atezolizumab Monotherapy Versus Regorafenib in Participants With Metastatic Colorectal Adenocarcinoma (COTEZO IMblaze370)
- Status
- COMPLETED
- Phase
- PHASE3